Pulmonary hypertension (PH) is a complex and progressive disease characterized by elevated pressures in the pulmonary arteries. It is a condition that can lead to severe complications if not accurately diagnosed and treated. This article aims to provide a comprehensive understanding of the fundamentals of PH for healthcare professionals.
The pathophysiology of PH is multifaceted, involving numerous pathways. It is primarily characterized by vasoconstriction, vascular remodeling, and thrombosis in situ, leading to increased pulmonary vascular resistance. Over time, this causes right ventricular hypertrophy and ultimately, right heart failure.
PH often presents with nonspecific symptoms such as dyspnea, fatigue, chest pain, and syncope. As the disease progresses, symptoms of right heart failure may become evident, including peripheral edema and ascites. The nonspecific nature of these symptoms often leads to delays in diagnosis.
Diagnosis of PH requires a high index of suspicion, given its insidious and nonspecific clinical presentation. It involves a combination of clinical assessment, echocardiography, and confirmatory right heart catheterization. Additional testing such as pulmonary function tests and computed tomography may be necessary in certain cases.
Treatment of PH is multi-faceted, focusing on symptom management, slowing disease progression, and improving quality of life. It may involve vasodilators, anticoagulation therapy, diuretics, and oxygen therapy. In severe cases, lung transplantation may be considered.
PH is a complex, progressive disease that requires a comprehensive understanding for effective management. Early recognition, accurate diagnosis, and appropriate treatment are crucial to improve patient outcomes. As healthcare professionals, it is our responsibility to stay informed about the latest advancements in PH management to provide optimal care for our patients.
1.
Guidelines for patient training and radiation protection for patients treated with radioactive iodine for thyroid cancer
2.
Acupuncture may alleviate nocturia in men treated for prostate cancer
3.
Inadvertent lung cancer screening results are discussed in a new study.
4.
Patients face high out-of-pocket costs after incident cancer diagnosis
5.
Rucaparib Delays Next Lines of Therapy in Ovarian Cancer
1.
Liquid Biopsy: A Revolutionary Tool for Early Detection and Monitoring of Colorectal Cancer
2.
The Basics of Langerhans Cell Histiocytosis: Understanding a Rare Disease
3.
Understanding Macrocytosis: Causes, Symptoms, and Treatment Options
4.
Unveiling the Mystery Behind Lymphovascular Invasion
5.
Cardio-Oncology: Managing Heart Failure in Survivors of Cancer
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion- Part II
2.
Current Cancer Scenario in India- Importance of Genomic Testing & Advancement in Diagnosis and Treatment
3.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
4.
The Landscape of First-Line Treatment for Urothelial Carcinoma- Further Discussion
5.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part IV
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation